1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow GEN-1: new trials by email Literature Review of GEN-1 trials Research Report on GEN-1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Laboratory Biomarker Analysis, PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1 - Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | Phase 2 | Completed | Gynecologic Oncology Group | 22 | 2010-11-01 | 2018-01-11 |
Fallopian Tube Neoplasms (1) · Ovarian Neoplasms (1)
Gynecologic Oncology Group (1)
United States (1)
Ronald Alvarez (1)
U10CA027469 (1), U10CA180868 (1)